Limiting Assumptions in the Design of Peptidomimetics.
- Published in:
- Drug Development Research, 2017, v. 78, n. 6, p. 245, doi. 10.1002/ddr.21406
- By:
- Publication type:
- Article
Works matching IS 02724391 AND DT 2017 AND VI 78 AND IP 6
Results: 9
1
2
Peptide Mimetic Drugs for Modulating Thrombosis and Hemostasis.
- Published in:
- Drug Development Research, 2017, v. 78, n. 6, p. 236, doi. 10.1002/ddr.21407
- By:
- Publication type:
- Article
3
Small Scaffolds, Big Potential: Developing Miniature Proteins as Therapeutic Agents.
- Published in:
- Drug Development Research, 2017, v. 78, n. 6, p. 268, doi. 10.1002/ddr.21408
- By:
- Publication type:
- Article
4
Peptide Technologies in the Development of Chemical Tools for Chromatin-Associated Machinery.
- Published in:
- Drug Development Research, 2017, v. 78, n. 6, p. 300, doi. 10.1002/ddr.21398
- By:
- Publication type:
- Article
5
RGD Peptide-Based Target Drug Delivery of Doxorubicin Nanomedicine.
- Published in:
- Drug Development Research, 2017, v. 78, n. 6, p. 283, doi. 10.1002/ddr.21399
- By:
- Publication type:
- Article
6
Issue Information - TOC.
- Published in:
- Drug Development Research, 2017, v. 78, n. 6, p. 227, doi. 10.1002/ddr.21360
- Publication type:
- Article
7
Peptide Mimetics: Fast-Forward Look.
- Published in:
- 2017
- By:
- Publication type:
- Editorial
8
Recent Advances in GLP-1 Receptor Agonists for Use in Diabetes Mellitus.
- Published in:
- Drug Development Research, 2017, v. 78, n. 6, p. 292, doi. 10.1002/ddr.21404
- By:
- Publication type:
- Article
9
On BH3 Mimetics and Ca<sup>2+</sup> Signaling.
- Published in:
- Drug Development Research, 2017, v. 78, n. 6, p. 313, doi. 10.1002/ddr.21405
- By:
- Publication type:
- Article